What is the Kwality Pharmaceuticals Ltd share price today?

The share price of NSE:KPL-EQ on 01 Oct 2026 (as of 15:04:04 IST) is ₹3562.4.

What is the NSE:KPL-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:KPL-EQ 52 week high low range shows a high of ₹3949 and a low of ₹1561.

What is the Kwality Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, Kwality Pharmaceuticals Ltd market cap is ₹37729900000.

What is the shareholding pattern of Kwality Pharmaceuticals Ltd Stock?

The shareholding pattern of Kwality Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 54.86% Foreign Institutional Investors (FII): 3.13% Domestic Institutional Investors (DII): 0.56% Mutual Funds: 0% Retail & Others: 41.45% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Kwality Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Kwality Pharmaceuticals Ltd is 46.5514, and the Price-to-Book (PB) ratio is 4.0977, as on 01 Oct 2026.

Kwality Pharmaceuticals Share Price

3630.90+115.00 (+3.27%)

+118.39% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+3.27%

1 Week

-1.35%

1 Month

+1.87%

3 Month

+41.88%

6 Month

+110.24%

YTD

1 Year

5 Year

10 Year

Max

+107.84%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

3506.30

3401.00

3226.60

2490.40

1642.10

1561.00

High

3669.90

3729.00

3783.90

3949.00

About

Kwality Pharmaceuticals Ltd. (formerly Kwality Pharmaceuticals Pvt. Ltd.) is a pharmaceutical formation company. It is engaged in manufacturing finished pharmaceutical formulations in dosage form. The company manufacture and export pharmaceutical Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

KPLNSE

LTP

1W Low

1W High

Market cap (₹)

1769.9+8.9 (0.51%)

1722

1855

4,24,202Cr

10064+400 (4.14%)

9621.50

10064

2,64,141Cr

4650+70 (1.53%)

4532

4675

1,74,402Cr

2323+79 (3.52%)

2206.10

2441.90

1,26,811Cr

1240.6+56.2 (4.75%)

1182

1254.20

1,23,685Cr

1368.3+23.3 (1.73%)

1336.70

1368.30

1,11,868Cr

1396.9+38.9 (2.86%)

1357

1396.90

1,11,650Cr

2475+5.7 (0.23%)

2457.90

2528

1,02,196Cr

1694.5+34.6 (2.08%)

1647.20

1697.40

96,951Cr

2015.9+26 (1.31%)

1974

2033.80

91,301Cr

3634.1-46.5 (-1.26%)

3401

3729

3,668Cr

Kwality Pharmaceuticals Share Price

3630.90+115.00 (+3.27%)

+118.39% past 1 Year

Financial overview

Compounded Sales Growth

10 years21%

5 years14%

3 years26%

Last year36%

Compounded Profit Growth

10 years46%

5 years35%

3 years51%

Last year69%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year-

Return on Equity

10 years26%

5 years32%

3 years17%

Last year23%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
21%	14%	26%	36%
46%	35%	51%	69%
-	-	-	-
26%	32%	17%	23%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

KPL

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
3,634.1	₹3668 Cr	45.26	24.7	97.43	₹67 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
₹162 Cr	₹157 Cr	₹123 Cr	₹111 Cr	₹111 Cr	₹116 Cr	₹84 Cr	₹90 Cr	₹80 Cr	₹92 Cr	₹78 Cr	₹70 Cr	₹67 Cr	₹69 Cr	₹56 Cr	₹56 Cr	₹70 Cr	₹64 Cr	₹88 Cr	₹184 Cr	₹120 Cr
₹62 L	₹1 Cr	₹53 L	₹90 L	₹38 L	₹77 L	₹66 L	₹22 L	₹28 L	₹58 L	₹62 L	₹23 L	₹40 L	₹1 Cr	₹35 L	₹1 Cr	₹38 L	₹2 Cr	₹84 L	₹12 L	₹96 L
₹163 Cr	₹158 Cr	₹124 Cr	₹112 Cr	₹112 Cr	₹116 Cr	₹85 Cr	₹90 Cr	₹80 Cr	₹93 Cr	₹79 Cr	₹70 Cr	₹68 Cr	₹70 Cr	₹57 Cr	₹57 Cr	₹71 Cr	₹66 Cr	₹89 Cr	₹184 Cr	₹121 Cr
₹126 Cr	₹124 Cr	₹98 Cr	₹91 Cr	₹92 Cr	₹95 Cr	₹71 Cr	₹75 Cr	₹67 Cr	₹76 Cr	₹66 Cr	₹59 Cr	₹58 Cr	₹62 Cr	₹45 Cr	₹44 Cr	₹55 Cr	₹51 Cr	₹67 Cr	₹103 Cr	₹75 Cr
₹42 Cr	₹40 Cr	₹30 Cr	₹26 Cr	₹25 Cr	₹27 Cr	₹18 Cr	₹20 Cr	₹18 Cr	₹21 Cr	₹17 Cr	₹15 Cr	₹14 Cr	₹13 Cr	₹15 Cr	₹17 Cr	₹18 Cr	₹18 Cr	₹25 Cr	₹84 Cr	₹48 Cr
₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹50 L	₹71 L	₹68 L
₹34 Cr	₹32 Cr	₹22 Cr	₹18 Cr	₹17 Cr	₹19 Cr	₹11 Cr	₹13 Cr	₹11 Cr	₹6 Cr	₹10 Cr	₹8 Cr	₹7 Cr	-₹10 Cr	₹10 Cr	₹12 Cr	₹14 Cr	₹14 Cr	₹22 Cr	₹80 Cr	₹46 Cr
₹26 Cr	₹25 Cr	₹16 Cr	₹14 Cr	₹12 Cr	₹14 Cr	₹9 Cr	₹8 Cr	₹8 Cr	₹4 Cr	₹8 Cr	₹6 Cr	₹5 Cr	-₹7 Cr	₹7 Cr	₹9 Cr	₹11 Cr	₹10 Cr	₹16 Cr	₹60 Cr	₹34 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Revaluation reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
—	—	—	—	—	—	—	—	—	—	—	—	—
₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹4 Cr
₹321 Cr	₹254 Cr	₹214 Cr	₹190 Cr	₹171 Cr	₹51 Cr	₹36 Cr	₹27 Cr	₹19 Cr	₹20 Cr	₹17 Cr	₹15 Cr	₹13 Cr
₹320 Cr	₹253 Cr	₹213 Cr	₹189 Cr	₹170 Cr	₹50 Cr	₹35 Cr	₹26 Cr	₹19 Cr	₹20 Cr	₹16 Cr	₹14 Cr	₹13 Cr
₹80 L	₹80 L	₹80 L	₹80 L	₹80 L	₹80 L	₹80 L	₹80 L	₹80 L	₹80 L	₹80 L	₹80 L	₹80 L
₹332 Cr	₹264 Cr	₹224 Cr	₹201 Cr	₹181 Cr	₹61 Cr	₹46 Cr	₹37 Cr	₹30 Cr	₹26 Cr	₹22 Cr	₹19 Cr	₹18 Cr
-₹2 Cr	-₹2 Cr	-₹2 Cr	-₹1 Cr	-₹1 Cr	-₹1 Cr	-₹1 Cr	-₹98 L	-₹99 L	-₹50 L	-₹41 L	-₹14 L	-₹3 L
₹29 Cr	₹15 Cr	₹20 Cr	₹27 Cr	₹20 Cr	₹16 Cr	₹8 Cr	₹7 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹30 L	₹54 L
₹0	₹0	₹0	₹12 L	₹70 L	₹2 Cr	₹2 Cr	₹58 L	₹2 Cr	₹67 L	₹35 L	₹50 L	₹87 L
-₹3 Cr	-₹2 Cr	-₹3 L	₹41 L	₹27 L	-₹4 L	-₹20 L	₹12 L	₹21 L	₹40 L	₹45 L	₹4 L	₹60 L
₹6 Cr	₹0	₹0	₹0	₹0	₹9 Cr	₹9 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹1 Cr	₹25 L	₹22 L	₹90 L	₹75 L	₹68 L	₹62 L	₹52 L	₹55 L	₹54 L	₹17 L	₹0	₹10 L
₹34 Cr	₹14 Cr	₹20 Cr	₹29 Cr	₹21 Cr	₹28 Cr	₹20 Cr	₹8 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹83 L	₹2 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—
₹102 Cr	₹56 Cr	₹44 Cr	₹35 Cr	₹35 Cr	₹26 Cr	₹23 Cr	₹17 Cr	₹22 Cr	₹13 Cr	₹10 Cr	₹4 Cr	₹7 Cr
₹30 Cr	₹24 Cr	₹35 Cr	₹33 Cr	₹41 Cr	₹30 Cr	₹21 Cr	₹22 Cr	₹16 Cr	₹11 Cr	₹6 Cr	₹6 Cr	₹4 Cr
₹85 Cr	₹83 Cr	₹66 Cr	₹51 Cr	₹23 Cr	₹16 Cr	₹21 Cr	₹19 Cr	₹21 Cr	₹15 Cr	₹10 Cr	₹7 Cr	₹4 Cr
₹9 Cr	₹6 Cr	₹7 Cr	₹6 Cr	₹41 Cr	₹6 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹1 Cr	₹58 L	₹2 L
₹226 Cr	₹170 Cr	₹152 Cr	₹126 Cr	₹139 Cr	₹78 Cr	₹68 Cr	₹61 Cr	₹62 Cr	₹42 Cr	₹27 Cr	₹17 Cr	₹15 Cr
₹590 Cr	₹446 Cr	₹394 Cr	₹354 Cr	₹341 Cr	₹166 Cr	₹132 Cr	₹105 Cr	₹96 Cr	₹71 Cr	₹51 Cr	₹37 Cr	₹35 Cr
₹37 Cr	₹37 Cr	₹35 L	₹51 L	₹5 L	₹59 L	₹1 Cr	₹5 Cr	₹0	₹0	₹0	₹0	₹0
₹130 Cr	₹112 Cr	₹98 Cr	₹90 Cr	₹54 Cr	₹41 Cr	₹35 Cr	₹29 Cr	₹26 Cr	₹19 Cr	₹13 Cr	₹8 Cr	₹6 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—
₹261 Cr	₹232 Cr	₹207 Cr	₹170 Cr	₹128 Cr	₹82 Cr	₹63 Cr	₹41 Cr	₹32 Cr	₹28 Cr	₹23 Cr	₹23 Cr	₹21 Cr
₹106 Cr	₹86 Cr	₹68 Cr	₹50 Cr	₹36 Cr	₹26 Cr	₹20 Cr	₹19 Cr	₹15 Cr	₹13 Cr	₹10 Cr	₹10 Cr	₹9 Cr
₹156 Cr	₹146 Cr	₹139 Cr	₹120 Cr	₹92 Cr	₹57 Cr	₹43 Cr	₹23 Cr	₹16 Cr	₹16 Cr	₹13 Cr	₹13 Cr	₹13 Cr
₹17 Cr	₹0	₹0	₹14 Cr	₹12 Cr	₹3 Cr	₹0	₹6 Cr	₹4 Cr	₹1 Cr	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹73 L	₹65 L	₹79 L	₹63 L	₹62 L	₹3 L	₹3 L	₹14 L
₹0	₹0	₹0	₹0	₹0	₹73 L	₹65 L	₹79 L	₹63 L	₹62 L	₹3 L	₹3 L	₹14 L
₹11 Cr	₹16 Cr	₹12 Cr	₹11 Cr	₹8 Cr	₹17 L	₹12 L	₹12 L	₹12 L	₹12 L	₹12 L	₹10 L	₹0
₹0	₹0	₹0	₹93 L	₹78 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹184 Cr	₹162 Cr	₹151 Cr	₹146 Cr	₹113 Cr	₹60 Cr	₹43 Cr	₹30 Cr	₹21 Cr	₹18 Cr	₹13 Cr	₹13 Cr	₹13 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—
₹0	₹0	₹0	₹0	₹0	₹4 Cr	₹3 Cr	₹4 Cr	₹5 Cr	₹3 Cr	₹2 Cr	₹97 L	₹50 L
₹78 Cr	₹83 Cr	₹78 Cr	₹86 Cr	₹53 Cr	₹17 Cr	₹22 Cr	₹11 Cr	₹15 Cr	₹14 Cr	₹10 Cr	₹6 Cr	₹7 Cr
₹280 Cr	₹154 Cr	₹114 Cr	₹72 Cr	₹69 Cr	₹36 Cr	₹30 Cr	₹38 Cr	₹37 Cr	₹23 Cr	₹18 Cr	₹9 Cr	₹7 Cr
₹4 Cr	₹15 Cr	₹6 Cr	₹7 Cr	₹13 Cr	₹6 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹90 L
₹30 L	₹0	₹7 Cr	₹0	₹0	₹9 L	₹12 L	₹6 L	₹12 L	₹5 L	₹6 L	₹3 L	₹7 L
₹43 Cr	₹31 Cr	₹37 Cr	₹42 Cr	₹92 Cr	₹42 Cr	₹31 Cr	₹20 Cr	₹16 Cr	₹11 Cr	₹6 Cr	₹7 Cr	₹7 Cr
₹406 Cr	₹284 Cr	₹243 Cr	₹207 Cr	₹228 Cr	₹106 Cr	₹89 Cr	₹75 Cr	₹75 Cr	₹53 Cr	₹38 Cr	₹24 Cr	₹22 Cr
₹180 Cr	₹114 Cr	₹91 Cr	₹81 Cr	₹88 Cr	₹28 Cr	₹21 Cr	₹15 Cr	₹13 Cr	₹11 Cr	₹12 Cr	₹7 Cr	₹7 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹3 L	₹7 L	₹10 L	₹14 L	₹0	₹0
₹590 Cr	₹446 Cr	₹394 Cr	₹354 Cr	₹341 Cr	₹166 Cr	₹132 Cr	₹105 Cr	₹96 Cr	₹71 Cr	₹51 Cr	₹37 Cr	₹35 Cr
₹319	₹254	₹215	₹192	₹174	₹58	₹44	₹35	₹28	₹48	₹42	₹42	₹39
₹319	₹254	₹215	₹192	₹174	₹58	₹44	₹35	₹28	₹24	₹21	₹21	₹19

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
₹89 Cr	₹54 Cr	₹31 Cr	₹26 Cr	₹162 Cr	₹21 Cr	₹11 Cr	₹11 Cr	₹7 Cr	₹6 Cr	₹2 Cr	₹1 Cr	₹2 Cr
₹31 Cr	₹28 Cr	₹37 Cr	₹21 Cr	₹14 Cr	₹9 Cr	₹7 Cr	₹5 Cr	₹4 Cr	₹5 Cr	₹3 Cr	₹2 Cr	₹2 Cr
-₹83 Cr	-₹14 Cr	-₹23 Cr	₹1 Cr	-₹73 Cr	₹3 Cr	-₹9 Cr	₹89 L	-₹9 Cr	-₹4 Cr	-₹7 Cr	-₹2 Cr	-₹4 Cr
₹37 Cr	₹69 Cr	₹44 Cr	₹48 Cr	₹102 Cr	₹33 Cr	₹9 Cr	₹17 Cr	₹2 Cr	₹7 Cr	-₹2 Cr	₹2 Cr	-₹28 L
₹17 Cr	₹53 Cr	₹43 Cr	₹41 Cr	₹61 Cr	₹27 Cr	₹6 Cr	₹14 Cr	-₹57 L	₹4 Cr	-₹3 Cr	₹1 Cr	-₹70 L
-₹35 Cr	-₹29 Cr	-₹26 Cr	-₹48 Cr	-₹63 Cr	-₹23 Cr	-₹18 Cr	-₹12 Cr	-₹6 Cr	-₹7 Cr	-₹2 Cr	-₹1 Cr	-₹3 Cr
₹7 Cr	-₹14 Cr	-₹17 Cr	₹99 L	₹6 Cr	₹77 L	₹12 Cr	-₹2 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹99 L	₹3 Cr
-₹11 Cr	₹10 Cr	-₹81 L	-₹6 Cr	₹3 Cr	₹4 Cr	₹14 L	-₹21 L	-₹1 Cr	₹2 Cr	₹31 L	₹79 L	-₹1 Cr
₹12 Cr	₹2 Cr	₹3 Cr	₹9 Cr	₹6 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹25 L	₹2 Cr
₹74 L	₹12 Cr	₹2 Cr	₹3 Cr	₹9 Cr	₹6 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹90 L

Fundamental Ratios

Consolidated

Standalone

No results found

Kwality Pharmaceuticals Share Price

3630.90+115.00 (+3.27%)

+118.39% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Open a free Demat account in minutes to start investing and screening .

Kwality Pharmaceuticals Share Price

3630.90+115.00 (+3.27%)

+118.39% past 1 Year

Shareholding summary

Promoters

54.86%

FII

2.5%

DII

1.07%

Others

41.57%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
54.86%	54.86%	54.87%	54.83%	54.83%	54.83%
2.50%	3.13%	2.79%	0.50%	0.00%	0.00%
1.07%	0.56%	0.36%	0.33%	0.33%	0.33%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
41.57%	41.45%	41.98%	44.34%	44.84%	44.84%

Bulk & block deals

Name

Deepak Bansal

Ark Global Emerging Companies, Lp

Aknm Suppliers Private Limited

Bluepeak Consultancy Llp

Aknm Suppliers Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
09 Jan 2026	Sell	7.78 Cr	₹1,122.42	69.35 K	Bulk	0.668385	BSE
09 Jan 2026	Purchase	8.63 Cr	₹1,130.04	76.40 K	Bulk	0.7363	BSE
10 Jul 2023	Sell	4.34 Cr	₹316.41	1.37 L	Bulk	1.321794	BSE
03 Jul 2023	Sell	4.43 Cr	₹295.10	1.50 L	Bulk	1.445616	BSE
03 Jul 2023	Purchase	2.21 Cr	₹295	75 K	Bulk	0.722808	BSE
30 Jun 2023	Sell	3.07 Cr	₹295.38	1.04 L	Bulk	1.002294	BSE
26 Jun 2023	Sell	4.66 Cr	₹294.07	1.59 L	Bulk	1.528151	BSE
08 Jun 2023	Sell	2.95 Cr	₹295.49	1 L	Bulk	0.963744	BSE
05 Jun 2023	Sell	2.95 Cr	₹295.19	1 L	Bulk	0.963744	BSE
19 Jan 2023	Sell	8.61 Cr	₹344.24	2.50 L	Bulk	2.40936	BSE

Insider trading & SAST

Client name

Aastha Seth

Ramesh Kumar

Aditya Arora

Ajay Kumar Arora

Aditya Arora

Aditya Arora & Pacs

Aditya Arora

Aknm Suppliers Pvt Ltd

Aditya Arora

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
18 Mar 2026	Directors Immediate Relative	Acquisition	0.009637	0.01	15.92 L	₹1,592.12	1 K	17 Mar 2026	Market Purchase	1,000	Insider Trading	—	Equity Shares
06 Mar 2026	Promoter	Acquisition	0.018774	26.03	30.33 L	₹1,556.85	1.95 K	05 Mar 2026	Market Purchase	27,00,632	Insider Trading	—	Equity Shares
05 Mar 2026	Promoter Group	Acquisition	0.009136	11.96	15.03 L	₹1,585.08	948	27 Feb 2026	Market Purchase	12,41,039	Insider Trading	—	Equity Shares
05 Mar 2026	Promoter	Acquisition	0.009069	13.6	14.92 L	₹1,585.02	941	27 Feb 2026	Market Purchase	14,11,579	Insider Trading	—	Equity Shares
04 Mar 2024	Promoter	Acquisition	0.01	11.95	0	—	1.20 K	16 Feb 2024	Market	12,40,091	SAST	29(2)	—
20 Feb 2024	Promoter	Acquisition	0.05	54.82	0	—	4.92 K	15 Feb 2024	Market	56,87,772	SAST	29(2)	—
17 Feb 2024	Promoter Group	Acquisition	0.047407	11.94	23.87 L	₹485.31	4.92 K	15 Feb 2024	Market Purchase	12,38,891	Insider Trading	—	Equity Shares
21 Jul 2023	Other	Disposal	1	2.77	0	—	1.04 L	30 Jun 2023	Market	2,87,152	SAST	29(2)	—
21 Jul 2023	Other	Acquisition	5	—	0	—	5.19 L	27 Jun 2023	-	—	SAST	10(6)	—
20 Jul 2023	Promoter	Acquisition	5	11.86	0	—	5.19 L	27 Jun 2023	Inter-se Transfer / Gift	12,30,772	SAST	29(2)	—

Kwality Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Kwality Pharmaceuticals Share Price

Kwality Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Kwality Pharmaceuticals Share Price

Kwality Pharmaceuticals Share Price

Oscillators

Moving averages

Kwality Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Kwality Pharmaceuticals Share Price

Corporate Actions

Company details

Kwality Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Kwality Pharmaceuticals Share Price

News

Kwality Pharma - Quaterly Results

Kwality Pharma projected FY27 revenue and profitability guidance signals strong growth outlook

Kwality Pharma reports Profit after tax of 25.29 Crores, in the March 2026 quarter

Kwality Pharma posts strong Q4 EBITDA growth with improved operating margins YoY

Kwality Pharma Q4 revenue rises sharply year on year, signaling strong topline growth

Kwality Pharma posts higher quarterly net profit on strong year on year growth

Kwality Pharmaceuticals informs about disclosure

Kwality Pharmaceuticals informs about investors meeting

Kwality Pharmaceuticals informs about press release

Kwality Pharma - Quaterly Results

Kwality Pharma reports Profit after tax of 16.01 Crores, in the December 2025 quarter

Kwality Pharmaceuticals informs about board meeting

Kwality Pharmaceuticals informs about confirmation certificate

Kwality Pharma reports Profit after tax of 14.12 Crores, in the September 2025 quarter

Kwality Pharmaceuticals informs about successful completion of the EU-GMP audit

Kwality Pharmaceuticals gets registration for Bleomycin in Mexico

Kwality Pharma - Quaterly Results

Kwality Pharma reports Profit after tax of 11.93 Crores, in the June 2025 quarter

Kwality Pharma - Quaterly Results

Kwality Pharma - Quaterly Results

Kwality Pharmaceuticals Ltd Share Price Today

Kwality Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator